Clinical Results

Researchers evaluated the effect of Cyperus rotundus rhizome extract on primary dysmenorrhea (painful menstruation) in women of reproductive age. The study measured pain intensity using a validated Visual Analogue Scale (VAS) over two menstrual cycles.

Supplementation with Cyperus rotundus extract produced statistically significant reductions in menstrual pain intensity compared to placebo, attributed to inhibition of prostaglandin synthesis and anti-spasmodic action on uterine smooth muscle tissue.

A landmark randomized, double-blind, placebo-controlled trial published in the BMJ assessed the efficacy of Vitex agnus-castus (Chaste Tree Berry) extract for the treatment of PMS. 178 women participated across three menstrual cycles, measuring irritability, mood alteration, anger, headache, bloating, and breast fullness.

Vitex was significantly superior to placebo across all measured PMS symptom clusters. 52% of Vitex-treated women reported symptom improvement versus 24% of the placebo group. The authors concluded Vitex agnus-castus is an effective and well-tolerated treatment for PMS.

This head-to-head randomized trial directly compared standardized ginger extract (250mg capsules, 4× daily) against ibuprofen (400mg) and mefenamic acid (250mg) for the treatment of primary dysmenorrhea in 150 female university students over two menstrual cycles.

Ginger extract was statistically non-inferior to both ibuprofen and mefenamic acid in reducing menstrual pain severity and duration, with no significant difference in outcomes between groups. Ginger produced no GI side effects — a significant advantage over NSAIDs used long-term.

A double-blind, placebo-controlled trial evaluated oral magnesium supplementation over two menstrual cycles in 32 women with confirmed PMS diagnoses. The study measured changes in mood, physical symptoms (bloating, weight gain), and pain using a validated Daily Symptom Report.

Magnesium supplementation significantly reduced premenstrual symptoms related to mood (negative affect), bloating, and pain versus placebo. Effects were most pronounced in the second cycle, consistent with the build-up behavior of magnesium supplementation in depleted cellular stores.

Researchers investigated the relationship between Vitamin D3 deficiency and primary dysmenorrhea severity. The trial supplemented D-deficient women with Vitamin D3 and tracked menstrual pain scores over two menstrual cycles, also measuring prostaglandin levels and uterine contractility markers.

Women with low baseline Vitamin D levels who supplemented showed significant reductions in dysmenorrhea pain scores and required less NSAID rescue medication. The researchers identified Vitamin D3's role in suppressing prostaglandin production in uterine tissue as the primary mechanism.

A systematic review and meta-analysis of nine published randomized trials evaluated the evidence for Vitamin B6 supplementation in the treatment of premenstrual syndrome, specifically examining emotional symptoms: depression, irritability, tiredness, and anxiety in the luteal phase.

The authors concluded that Vitamin B6 is likely to be of benefit in treating premenstrual emotional symptoms including depression. Odds ratio for improvement was 2.32 (95% CI: 1.95–2.54) — meaning women taking B6 were over twice as likely to report improvement in PMS mood symptoms compared to placebo.

The landmark Shoba et al. pharmacokinetic study measured serum curcumin concentrations in human subjects following oral administration of curcumin alone versus curcumin co-administered with 20mg piperine (Black Pepper extract). Blood samples were taken at multiple time points over 4 hours post-ingestion.

Co-administration of piperine with curcumin produced a 2,000% increase in serum curcumin bioavailability in human subjects compared to curcumin alone, with no adverse effects at the doses used. This study established piperine as the gold-standard bioavailability enhancer for curcumin — and by extension, for other poorly absorbed phytochemicals.